Tag: Eli Lilly
Lilly Becomes First Healthcare Company Worth $1 Trillion
Eli Lilly reached a market value of $1 trillion on Friday, becoming the first healthcare and pharmaceutical company to enter a group usually led...
Lilly’s New Obesity Drug Enters Late-Stage Testing After Breakthrough Results
Eli Lilly to Begin Late-Stage Trials After Obesity Drug Shows Major Weight Loss Results
Eli Lilly announced on Thursday that it will begin late-stage clinical...
Boardroom Battle at Novo Nordisk May Sharpen Its U.S. Growth Plan
Novo Boardroom Shake-Up Aims to Refocus on U.S. Weight-Loss Market
Boardroom tensions at Novo Nordisk, the Danish maker of Wegovy, have exposed the company’s biggest...
Roche, Lilly Secure U.S. Greenlight for Alzheimer’s Detection Test
Roche and Eli Lilly Receive U.S. FDA Approval for Alzheimer’s Blood Test
Roche Diagnostics announced on Monday that the U.S. Food and Drug Administration (FDA)...
After Pfizer: Is AstraZeneca or Eli Lilly Next?
After Pfizer’s Price Deal, Analysts Point to Eli Lilly and AstraZeneca
Wall Street is turning its attention to Eli Lilly and AstraZeneca as the next...
Eli Lilly Plans $5 Billion Virginia Plant Amid Looming Pharma Tariffs
Eli Lilly to Invest $5 Billion in New Virginia Manufacturing Plant
Pharmaceutical giant Eli Lilly announced Tuesday that it will invest $5 billion to build...
Novo Nordisk Lays Off 9,000 Workers as Weight-Loss Drug Competition Heats...
Novo Nordisk Cuts 9,000 Jobs in Major Restructuring Amid Weight-Loss Drug Battle
Novo Nordisk, the pharmaceutical giant behind the blockbuster weight-loss drug Wegovy, announced on...
S&P 500 Advances as Gains in Health Care and Tech Outweigh...
The S&P 500 edged higher on Tuesday as gains in health care and technology stocks helped offset renewed concerns over Federal Reserve independence, just...
